THE IMPORTANCE OF QUANTIFERON-TB GOLD TEST IN DIAGNOSING LATENT TUBERCULOSIS INFECTION

Main Article Content

Аннотация:

Latent tuberculosis infection remains one of the most persistent global public health threats. It is estimated by the World Health Organization (WHO) that approximately 25 percent of the world's population is infected with latent tuberculosis bacilli. Although individuals with latent tuberculosis do not show clinical symptoms and are not contagious, around 5 to 10 percent of them will eventually develop active tuberculosis disease during their lifetime, particularly when the immune system is weakened. Therefore, early detection and preventive treatment of latent tuberculosis infection are critical components in breaking the transmission cycle of tuberculosis. The QuantiFERON-TB Gold test has become an important diagnostic tool for identifying latent tuberculosis infection, particularly in settings where Bacille Calmette-Guérin (BCG) vaccination is common, which can reduce the specificity of the traditional Tuberculin Skin Test (TST). This interferon-gamma release assay provides greater accuracy, faster results, and fewer false positives caused by previous BCG vaccination or exposure to non-tuberculous mycobacteria.

Article Details

Как цитировать:

Gaffarov , . B., Akbarova , M., & Massavirov, S. . (2025). THE IMPORTANCE OF QUANTIFERON-TB GOLD TEST IN DIAGNOSING LATENT TUBERCULOSIS INFECTION. Инновационные исследования в современном мире: теория и практика, 4(26), 23–24. извлечено от https://www.in-academy.uz/index.php/zdit/article/view/57811

Библиографические ссылки:

World Health Organization. (2023). Global tuberculosis report 2023. WHO. https://www.who.int/publications/i/item/9789240076729

Centers for Disease Control and Prevention. (2022). Latent TB Infection: A Guide for Primary Health Care Providers.

https://www.cdc.gov/tb/publications/ltbi/pdf/ltbiguide508.pdf

Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., ... & Raviglione, M. (2022). Tuberculosis. Nature Reviews Disease Primers, 8(1), 1-27. https://doi.org/10.1038/s41572-022-00331-3

Getahun, H., Matteelli, A., Abubakar, I., Aziz, M. A., & Baddeley, A. (2021). Advancing latent tuberculosis infection diagnosis and treatment: new tools and strategies. The Lancet Infectious Diseases, 21(3), e52-e62.

https://doi.org/10.1016/S1473-3099(20)30308-2

Winje, B. A., Oftung, F., & Heldal, E. (2020). QuantiFERON-TB Gold Plus performance in immigrants: A population-based evaluation. BMC Infectious Diseases, 20(1), 1-9. https://doi.org/10.1186/s12879-020-05176-7